This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

£200 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
4 - 6 June, 2024
Excel London Platinum Suite

Bart-Jan de Kreuk, Ph.D.
Senior Scientist, Antibody Format Discovery at Genmab


Bart-Jan de Kreuk, Ph.D., is a Senior Scientist at Genmab. He obtained his Ph.D. in 2012 in Cell Biology at Sanquin Research (Amsterdam, the Netherlands), studying the role of small GTPases in cell adhesion and migration. After receiving his PhD degree, he moved to the lab of Professor Mark Ginsberg at UCSD (San Diego, USA) as a post-doctoral fellow studying how small GTPases affect endothelial membrane integrity and as such may influence Cerebral Cavernous Malformations. He joined Genmab in 2016 where his focus is on Antibody biology and Fc/antibody engineering as well as discovery of new antibody format opportunities.

Agenda Sessions

  • Maximizing TNFRSF Agonistic Activity of Monoclonal Antibodies by Promoting Antibody Fc-Fc Interactions